Literature DB >> 24875359

MiR-124 protects human hepatic L02 cells from H2O2-induced apoptosis by targeting Rab38 gene.

Xiaohua Li1, Shuhong Yi2, Yinan Deng1, Jintao Cheng1, Xiaocai Wu1, Wei Liu1, Yan Tai3, Guihua Chen1, Qi Zhang1, Yang Yang4.   

Abstract

BACKGROUND: Hepatic ischemia reperfusion injury (IRI) is an inevitable clinical problem for liver surgeons. Because microRNAs (miRNAs) participate in various hepatic pathophysiological processes, this study aimed to explore the role and potential mechanism of miR-124 in hepatic IRI.
METHODS: A liver IRI model was established in rats. The differential expression of miRNAs was detected using microarrays, and the expression of miR-124 was measured by qRT-PCR. A hydrogen peroxide (H2O2)-induced oxidative stress apoptosis model was also established. Cell apoptosis was detected by flow cytometry, and viability was detected by CCK8. The expression of Rab38 was detected by Western blotting and qRT-PCR, and a luciferase reporter assay was used to verify the expression of the miR-124 target gene.
RESULTS: The miRNA spectrum changes dramatically after hepatic IRI in rats, and miR-124 is significantly down-regulated after liver IRI. MiR-124 decreases the H2O2-induced apoptosis of human hepatic L02 cells by up-regulating the activation of the AKT pathway. Rab38 is a target gene of miR-124 and is involved in H2O2-induced apoptosis. Interference with the expression of the Rab38 gene can protect hepatic L02 from H2O2-induced apoptosis by increasing the phosphorylation of AKT. These protective effects of miR-124 are attenuated by over-expression of Rab38.
CONCLUSIONS: Many miRNAs are involved in hepatic IRI in rats, and miR-124 is significantly decreased in this model. MiR-124 significantly decreases the H2O2-induced apoptosis of human hepatic L02 cells by targeting the Rab38 gene and activating the AKT pathway.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  L02 cells; Liver ischemia reperfusion injury; MiR-124; Rab38

Mesh:

Substances:

Year:  2014        PMID: 24875359     DOI: 10.1016/j.bbrc.2014.05.085

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  8 in total

1.  Total Glucosides of Paeony Alleviate Cell Apoptosis and Inflammation by Targeting the Long Noncoding RNA XIST/MicroRNA-124-3p/ITGB1 Axis in Renal Ischemia/Reperfusion Injury.

Authors:  Fang Chen; Yi Hu; Yuetao Xie; Zonghui Zhao; Lin Ma; Zhili Li; Wanlong Tan
Journal:  Mediators Inflamm       Date:  2020-11-24       Impact factor: 4.711

2.  MiR-124 effect in neurons apoptosis in newborn rat with thyroid hypofunction.

Authors:  Qingliang Shao; Wei Jiang; Yan Jin
Journal:  Int J Clin Exp Pathol       Date:  2015-11-01

3.  miR-706 inhibits the oxidative stress-induced activation of PKCα/TAOK1 in liver fibrogenesis.

Authors:  Ruili Yin; Duo Guo; Shuxian Zhang; Xiuying Zhang
Journal:  Sci Rep       Date:  2016-11-23       Impact factor: 4.379

4.  miR-494 up-regulates the PI3K/Akt pathway via targetting PTEN and attenuates hepatic ischemia/reperfusion injury in a rat model.

Authors:  Song Su; Xiangdong Liu; Jiang Liu; Fangyi Peng; Cheng Fang; Bo Li
Journal:  Biosci Rep       Date:  2017-09-19       Impact factor: 3.840

Review 5.  Novel Targets for Treating Ischemia-Reperfusion Injury in the Liver.

Authors:  Weili Yang; Ji Chen; Yuhong Meng; Zhenzhen Chen; Jichun Yang
Journal:  Int J Mol Sci       Date:  2018-04-26       Impact factor: 5.923

6.  Hepatoprotective effects of sevoflurane against hepatic ischemia-reperfusion injury by regulating microRNA-124-3p-mediated TRAF3/CREB axis.

Authors:  Yi-Liang Wang; Ying Zhang; Da-Sheng Cai
Journal:  Cell Death Discov       Date:  2022-03-08

Review 7.  MicroRNAs as Signaling Mediators and Biomarkers of Drug- and Chemical-Induced Liver Injury.

Authors:  Mitchell R McGill; Hartmut Jaeschke
Journal:  J Clin Med       Date:  2015-05-20       Impact factor: 4.964

8.  YAP-Dependent Induction of CD47-Enriched Extracellular Vesicles Inhibits Dendritic Cell Activation and Ameliorates Hepatic Ischemia-Reperfusion Injury.

Authors:  Zenan Yuan; Linsen Ye; Xiao Feng; Tian Zhou; Yi Zhou; Shuguang Zhu; Changchang Jia; Haibo Li; Dongbo Qiu; Kun Li; Wei Liu; Yang Li; Hui Tang; Guoying Wang; Qi Zhang; Yang Yang; Guihua Chen; Hua Li
Journal:  Oxid Med Cell Longev       Date:  2021-06-22       Impact factor: 6.543

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.